{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T11:07:02Z","timestamp":1759057622218,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008127","name":"Universiti Malaysia Sarawak","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008127","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cerebellar degeneration is a rare and severe presentation of primary Sj\u00f6gren syndrome. There are few case reports of cerebellar degeneration associated with different autoimmune diseases, especially with systemic lupus erythematosus and neuro-Behcet\u2019s disease. There are only six patients reported worldwide to be affected by cerebellar atrophy associated with primary Sj\u00f6gren syndrome. In this report, we describe a patient with primary Sj\u00f6gren syndrome who presented with ataxia due to cerebellar degeneration.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We report the case of a 37-year-old Chinese woman with primary Sj\u00f6gren syndrome who presented with ataxia over 3\u00a0months associated with tremor of the limbs. Magnetic resonance imaging of the brain revealed bilateral cerebellar atrophy. Based on the presence of cerebellar signs with magnetic resonance imaging brain findings, she was diagnosed as cerebellar degeneration secondary to primary Sj\u00f6gren syndrome. She was treated with methylprednisolone, hydroxychloroquine, and two cycles of monthly intravenous cyclophosphamide. Subsequently, she refused further treatment, and her neurological symptoms remained the same upon the last clinic review. Primary cerebellar degeneration is rarely associated with primary Sj\u00f6gren syndrome. The pathogenesis of the neurological manifestations in primary Sj\u00f6gren syndrome is unclear. Treatment involves corticosteroids and immunosuppressive agents with no consensus of a specific therapy for the management of primary Sj\u00f6gren syndrome with central nervous system involvement.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Cerebellar degeneration is a rare presentation of primary Sj\u00f6gren syndrome. Early diagnosis and treatment of this condition is needed to ensure a good outcome.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-021-03103-x","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T23:49:16Z","timestamp":1634600956000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Cerebellar degeneration in primary Sj\u00f6gren syndrome: a case report"],"prefix":"10.1186","volume":"15","author":[{"given":"Seow Lin","family":"Chuah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8499-3315","authenticated-orcid":false,"given":"Ahmad Tirmizi","family":"Jobli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharifah Aishah","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng Lay","family":"Teh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"key":"3103_CR1","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1001\/archinte.164.12.1275","volume":"164","author":"SS Kassan","year":"2004","unstructured":"Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sj\u00f6gren syndrome. Arch Intern Med. 2004;164:1275\u201384.","journal-title":"Arch Intern Med"},{"issue":"5","key":"3103_CR2","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","volume":"29","author":"FN Skopouli","year":"2000","unstructured":"Skopouli FN, Dafni U, Loannidis JP, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sj\u00f6gren\u2019s syndrome. Semin Arthritis Rheum. 2000;29(5):296\u2013304.","journal-title":"Semin Arthritis Rheum"},{"key":"3103_CR3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.lpm.2012.06.002","volume":"41","author":"AL Fauchais","year":"2012","unstructured":"Fauchais AL, Magy L, Vidal E. Central and peripheral neurological complications of primary Sj\u00f6gren\u2019s syndrome. Presse Med. 2012;41:485\u201393.","journal-title":"Presse Med"},{"key":"3103_CR4","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S0889-857X(21)00321-5","volume":"18","author":"E Alexander","year":"1992","unstructured":"Alexander E. Central nervous system disease in Sj\u00f6gren\u2019s syndrome. New insights into immunopathogenesis. Rheum Dis Clin N Am. 1992;18:637\u201372.","journal-title":"Rheum Dis Clin N Am"},{"key":"3103_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1600-0404.1994.tb01629.x","volume":"89","author":"E Mauch","year":"1994","unstructured":"Mauch E, V\u00f6lk C, Kratzsch G, Krapf H, Kornhuber HH, Laufen H, et\u00a0al. Neurological and neuropsychiatric dysfunction in primary Sj\u00f6gren\u2019s syndrome. Acta Neurol Scand. 1994;89:31\u20135.","journal-title":"Acta Neurol Scand"},{"key":"3103_CR6","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","volume":"83","author":"S Delalande","year":"2004","unstructured":"Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, et\u00a0al. Neurologic manifestations in primary Sj\u00f6gren syndrome: a study of 82 patients. Medicine. 2004;83:280\u201391.","journal-title":"Medicine"},{"key":"3103_CR7","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1097\/WCO.0b013e32833de6ab","volume":"23","author":"J Chai","year":"2010","unstructured":"Chai J, Logigian EL. Neurological manifestations of primary Sj\u00f6gren\u2019s syndrome. Curr Opin Neurol. 2010;23:509\u201313.","journal-title":"Curr Opin Neurol"},{"key":"3103_CR8","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0889-857X(21)00212-X","volume":"19","author":"HN Moutsopoulos","year":"1993","unstructured":"Moutsopoulos HN, Sarmas JH, Talal N. Is central nervous system involvement a systemic manifestation of primary Sj\u00f6gren\u2019s syndrome? Rheum Dis Clin N Am. 1993;19:909\u201312.","journal-title":"Rheum Dis Clin N Am"},{"key":"3103_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1093\/rheumatology\/29.1.21","volume":"29","author":"AP Andonopoulos","year":"1990","unstructured":"Andonopoulos AP, Lagos G, Drosos AA, Moutsopoulos HM. The spectrum of neurological involvement in Sj\u00f6gren\u2019s syndrome. Br J Rheumatol. 1990;29:21\u20133.","journal-title":"Br J Rheumatol"},{"key":"3103_CR10","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1093\/rheumatology\/keq111","volume":"49","author":"A Massara","year":"2010","unstructured":"Massara A, Bonazza S, Castellino G, Caniatti L, Trotta F, Borrelli M, et\u00a0al. Central nervous system involvement in Sj\u00f6gren\u2019s syndrome: unusual, but not unremarkable clinical, serological characteristics and outcomes in a large cohort of Italian patients. Rheumatology. 2010;49:1540\u20139.","journal-title":"Rheumatology"},{"key":"3103_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0022-510X(02)00034-5","volume":"197","author":"K Owada","year":"2002","unstructured":"Owada K, Uchihara T, Ishida K, Mizusawa H, Watabiki S, Tsuchiya K. Motor weakness and cerebellar ataxia in Sj\u00f6gren syndrome\u2014identification of antineuronal antibody: a case report. J Neurol Sci. 2002;197:79\u201384.","journal-title":"J Neurol Sci"},{"key":"3103_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0303-8467(96)00013-3","volume":"98","author":"MU Manto","year":"1996","unstructured":"Manto MU, Rondeaux P, Jacquy J, Hildebrand JG. Subacute pancerebellar syndrome associated with systemic lupus erythematosus. Clin Neurol Neurosurg. 1996;98:157\u201360.","journal-title":"Clin Neurol Neurosurg"},{"key":"3103_CR13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0140-6736(93)91524-P","volume":"342","author":"T Shimomura","year":"1993","unstructured":"Shimomura T, Kuno N, Takenaka T, Maeda M, Takahashi K. Purkinje cell antibody in lupus ataxia. Lancet. 1993;342:375\u20136.","journal-title":"Lancet"},{"key":"3103_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/mds.21834","volume":"23","author":"RC Gardner","year":"2008","unstructured":"Gardner RC, Schmahmann JD. Ataxia and cerebellar atrophy\u2014a novel manifestation of neuro-Beh\u00e7et disease? Mov Disord. 2008;23:307\u20138.","journal-title":"Mov Disord"},{"key":"3103_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00296-006-0171-y","volume":"27","author":"M Hirose","year":"2006","unstructured":"Hirose M, Ikeuchi T, Hayashi S, Terajima K, Endo K, Hayashi T, et\u00a0al. A possible variant of neuro-Beh\u00e7et disease presenting chronic progressive ataxia without mucocutaneo-ocular symptoms. Rheumatol Int. 2006;27:61\u20135.","journal-title":"Rheumatol Int"},{"key":"3103_CR16","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1212\/WNL.50.1.244","volume":"50","author":"M Tagliati","year":"1998","unstructured":"Tagliati M, Simpsom D, Morgello S, Clifford D, Schwartz RL, Berger JR. Cerebellar degeneration associated with human immunodeficiency virus infection. Neurology. 1998;50:244\u201351.","journal-title":"Neurology"},{"key":"3103_CR17","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1212\/WNL.11.12.1034","volume":"11","author":"W Attwood","year":"1961","unstructured":"Attwood W, Poser CM. Neurologic complications of Sj\u00f6gren\u2019s syndrome. Neurology. 1961;11:1034\u201341.","journal-title":"Neurology"},{"key":"3103_CR18","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/S0140-6736(94)91864-3","volume":"343","author":"Y Terao","year":"1994","unstructured":"Terao Y, Sakai K, Kato S, Tanabe H, Ishida K, Tsukamoto T. Antineuronal antibody in Sj\u00f6gren\u2019s syndrome masquerading as paraneoplastic cerebellar degeneration. Lancet. 1994;343:790.","journal-title":"Lancet"},{"key":"3103_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2017-223952","author":"M Heidary","year":"2018","unstructured":"Heidary M, Alesaeidi S, Afshari K. Cerebellar degeneration in primary Sj\u00f6gren syndrome. BMJ Case Rep. 2018. https:\/\/doi.org\/10.1136\/bcr-2017-223952.","journal-title":"BMJ Case Rep"},{"key":"3103_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3988\/jcn.2012.8.2.155","volume":"8","author":"MJ Kim","year":"2012","unstructured":"Kim MJ, Lee MC, Lee JH, Chung SJ. Cerebellar degeneration associated with Sj\u00f6gren\u2019s syndrome. J Clin Neurol. 2012;8:155\u20139.","journal-title":"J Clin Neurol"},{"key":"3103_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40673-016-0056-0","volume":"3","author":"E Farhat","year":"2016","unstructured":"Farhat E, Zouari M, Abdelaziz IB, Drissi C, Beyrouti R, Hammouda MB, et\u00a0al. Progressive cerebellar degeneration revealing Primary Sj\u00f6gren Syndrome: a case report. Cerebellum Ataxias. 2016;3:18.","journal-title":"Cerebellum Ataxias"},{"key":"3103_CR22","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/mdc3.12487","volume":"4","author":"R Maciel","year":"2017","unstructured":"Maciel R, Camargos S, Cardoso F. Subacute cerebellar degeneration as the first manifestation of Sj\u00f6gren\u2019s syndrome. Mov Disord Clin Pract. 2017;4:637\u20138.","journal-title":"Mov Disord Clin Pract"},{"key":"3103_CR23","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/art.1780291007","volume":"29","author":"EL Alexander","year":"1986","unstructured":"Alexander EL, Lijewski JE, Jerdan MS, Alexander GE. Evidence of an immunopathogenic basis for central nervous system disease in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheum. 1986;29:1223\u201331.","journal-title":"Arthritis Rheum"},{"key":"3103_CR24","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","volume":"165","author":"E Zintzaras","year":"2005","unstructured":"Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med. 2005;165:2337\u201344.","journal-title":"Arch Intern Med"},{"key":"3103_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/bjh.13192","volume":"168","author":"G Nocturne","year":"2015","unstructured":"Nocturne G, Mariette X. Sj\u00f6gren syndrome-associated lymphomas: an update on pathogenesis and management. Br J Haematol. 2015;168:317\u201327.","journal-title":"Br J Haematol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-03103-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-021-03103-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-021-03103-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:18:29Z","timestamp":1634602709000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-021-03103-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3103"],"URL":"https:\/\/doi.org\/10.1186\/s13256-021-03103-x","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2021,10,19]]},"assertion":[{"value":"1 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case report was approved by the Director-General of the Ministry of Health, Malaysia.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"526"}}